Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Goto

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|April 29, 2026
Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphomaLoretta Jo Nastoupil, Alejandro Martín García-Sancho, Koji Izutsu, et al.
Blood Advances|April 22, 2026
Drivers of Temporal Improvement in CAR T-Cell Therapy for Large B-Cell Lymphoma: A Japanese Nationwide Registry AnalysisYu Yagi, Yusuke Kanemasa, Toshiki Terao, et al.
Internal Medicine (Tokyo, Japan)|April 17, 2024
Acute Onset of Constrictive Pericarditis Due to Acute Myelomonocytic Leukemia: A Case and Literature ReviewNaoki Kosaka, Takanori Uchiyama, Masahiro Onozawa, et al.
Cytotherapy|January 16, 2026
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registryMasatoshi Sakurai, Yasuyuki Arai, Hideki Goto, et al.
International Journal of Hematology|December 3, 2025
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)Atsushi Satake, Yasuhiro Nagate, Kohta Miyawaki, et al.
British Journal of Haematology|April 17, 2023
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosisShota Yokoyama, Masahiro Onozawa, Shota Yoshida, et al.
Haematologica|June 13, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study GroupKoh Izumiyama, Tasuku Inao, Hideki Goto, et al.
European Journal of Haematology|July 19, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AMLToru Miyajima, Masahiro Onozawa, Shota Yoshida, et al.
International Journal of Hematology|April 22, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort studyShota Yokoyama, Masahiro Onozawa, Hiroyuki Kimura, et al.
Annals of Hematology|August 19, 2023
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemiaHiroyuki Kimura, Masahiro Onozawa, Shota Yoshida, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|April 29, 2026
Comparative outcomes of lisocabtagene maraleucel versus an external control arm in third-line or later relapsed or refractory follicular lymphomaLoretta Jo Nastoupil, Alejandro Martín García-Sancho, Koji Izutsu, et al.
Blood Advances|April 22, 2026
Drivers of Temporal Improvement in CAR T-Cell Therapy for Large B-Cell Lymphoma: A Japanese Nationwide Registry AnalysisYu Yagi, Yusuke Kanemasa, Toshiki Terao, et al.
Internal Medicine (Tokyo, Japan)|April 17, 2024
Acute Onset of Constrictive Pericarditis Due to Acute Myelomonocytic Leukemia: A Case and Literature ReviewNaoki Kosaka, Takanori Uchiyama, Masahiro Onozawa, et al.
Cytotherapy|January 16, 2026
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registryMasatoshi Sakurai, Yasuyuki Arai, Hideki Goto, et al.
International Journal of Hematology|December 3, 2025
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)Atsushi Satake, Yasuhiro Nagate, Kohta Miyawaki, et al.
British Journal of Haematology|April 17, 2023
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosisShota Yokoyama, Masahiro Onozawa, Shota Yoshida, et al.
Haematologica|June 13, 2024
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study GroupKoh Izumiyama, Tasuku Inao, Hideki Goto, et al.
European Journal of Haematology|July 19, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AMLToru Miyajima, Masahiro Onozawa, Shota Yoshida, et al.
International Journal of Hematology|April 22, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort studyShota Yokoyama, Masahiro Onozawa, Hiroyuki Kimura, et al.
Annals of Hematology|August 19, 2023
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemiaHiroyuki Kimura, Masahiro Onozawa, Shota Yoshida, et al.
Pageof 10